US Stock MarketDetailed Quotes

Mereo BioPharma (MREO)

Watchlist
  • 0.2595
  • +0.0135+5.49%
Close May 13 16:00 ET
  • 0.2500
  • -0.0095-3.66%
Post 19:40 ET
41.42MMarket Cap-1.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mereo BioPharma (MREO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.67%-30.97M
18.45%-7.68M
2.79%-7.31M
3.20%-7.65M
-4.23%-8.33M
-55.38%-32.83M
-38.75%-9.42M
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
Net income from continuing operations
3.18%-41.88M
-4.33%-7.35M
53.17%-7.02M
-19.25%-14.62M
-43.97%-12.89M
-46.79%-43.25M
22.65%-7.05M
-129.69%-15M
-600.00%-12.26M
25.88%-8.95M
Operating gains losses
787.10%5.44M
96.19%-272K
-131.91%-2.07M
14,181.58%5.43M
1,523.64%2.35M
-137.63%-791K
-338.47%-7.15M
363.00%6.48M
-95.80%38K
-124.81%-165K
Depreciation and amortization
5.61%1.15M
116.06%592K
-103.90%-11K
15.95%298K
-1.82%270K
2.54%1.09M
-2.49%274K
0.00%282K
-5.17%257K
21.15%275K
Other non cash items
-102.32%-72K
-97.56%52K
-188.30%-317K
-94.17%18K
-42.81%175K
68.53%3.1M
544.55%2.13M
-46.58%359K
-65.97%309K
537.14%306K
Change In working capital
-768.02%-3.2M
-362.08%-2.25M
128.96%400K
-150.75%-843K
65.87%-514K
76.84%-369K
140.75%857K
-115.06%-1.38M
118.40%1.66M
-505.93%-1.51M
-Change in receivables
184.66%1.4M
17.88%-473K
834.96%1.66M
-101.08%-744K
299.58%952K
-461.62%-1.65M
-183.72%-576K
-113.36%-226K
74.04%-370K
4.41%-477K
-Change in prepaid assets
-102.82%-84K
-83.97%235K
-118.85%-164K
108.73%113K
-113.82%-268K
493.63%2.98M
176.55%1.47M
-89.79%870K
86.22%-1.3M
-41.10%1.94M
-Change in payables and accrued expense
-260.61%-3.77M
-1,424.09%-1.81M
51.05%-909K
-100.60%-21K
63.44%-1.03M
46.98%-1.05M
118.87%137K
-105.88%-1.86M
79.60%3.49M
-23.01%-2.81M
-Change in other current liabilities
-13.61%-743K
-14.12%-194K
-11.90%-188K
-19.38%-191K
-8.97%-170K
-13.15%-654K
-13.33%-170K
-13.51%-168K
-11.11%-160K
-14.71%-156K
Cash from discontinued investing activities
Operating cash flow
5.67%-30.97M
18.45%-7.68M
2.79%-7.31M
3.20%-7.65M
-4.23%-8.33M
-55.38%-32.83M
-38.75%-9.42M
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
Investing cash flow
Cash flow from continuing investing activities
97.14%-20K
0
300K
0
54.29%-320K
-66.83%-699K
0
0
1K
-67.06%-700K
Net PPE purchase and sale
---20K
--0
--0
--0
---20K
--0
--0
--0
--0
--0
Net intangibles purchase and sale
57.08%-300K
--0
--0
--0
57.14%-300K
-66.83%-699K
--0
--0
--1K
-67.06%-700K
Net other investing changes
--300K
--0
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
97.14%-20K
--0
--300K
--0
54.29%-320K
-66.83%-699K
--0
--0
--1K
-67.06%-700K
Financing cash flow
Cash flow from continuing financing activities
-99.29%327K
197.50%39K
0
-100.29%-134K
422K
478.79%46.15M
-40K
-107.51%-594K
46.78M
0
Net issuance payments of debt
----
----
----
----
----
--0
--0
----
----
----
Net common stock issuance
-99.92%39K
--39K
--0
----
----
305.00%47M
--0
--0
----
----
Proceeds from stock option exercised by employees
--487K
--0
--0
--0
--487K
--0
--0
--0
--0
--0
Net other financing activities
76.67%-199K
--0
--0
---134K
---65K
-92.12%-853K
---40K
-16.24%-594K
----
----
Cash from discontinued financing activities
Financing cash flow
-99.29%327K
197.50%39K
--0
-100.29%-134K
--422K
478.79%46.15M
---40K
-107.51%-594K
--46.78M
--0
Net cash flow
Beginning cash position
21.56%69.8M
-39.52%48.7M
-35.81%56.13M
28.41%62.48M
21.56%69.8M
-15.78%57.42M
28.78%80.52M
65.07%87.43M
-18.64%48.66M
-15.78%57.42M
Current changes in cash
-343.09%-30.66M
19.21%-7.64M
13.61%-7.01M
-120.02%-7.79M
5.34%-8.23M
192.89%12.61M
-39.32%-9.46M
-176.79%-8.11M
605.76%38.88M
10.10%-8.69M
Effect of exchange rate changes
895.71%1.85M
95.00%-63K
-134.72%-418K
1,433.64%1.43M
1,397.14%908K
-108.27%-233K
-174.91%-1.26M
220.04%1.2M
-112.65%-107K
-105.41%-70K
End cash Position
-41.27%40.99M
-41.27%40.99M
-39.52%48.7M
-35.81%56.13M
28.41%62.48M
21.56%69.8M
21.56%69.8M
28.78%80.52M
65.07%87.43M
-18.64%48.66M
Free cash flow
6.69%-31.29M
18.45%-7.68M
2.79%-7.31M
3.19%-7.65M
0.48%-8.65M
-55.60%-33.53M
-38.75%-9.42M
-382.78%-7.52M
-1.92%-7.9M
10.10%-8.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.67%-30.97M18.45%-7.68M2.79%-7.31M3.20%-7.65M-4.23%-8.33M-55.38%-32.83M-38.75%-9.42M-382.78%-7.52M-1.93%-7.9M13.59%-7.99M
Net income from continuing operations 3.18%-41.88M-4.33%-7.35M53.17%-7.02M-19.25%-14.62M-43.97%-12.89M-46.79%-43.25M22.65%-7.05M-129.69%-15M-600.00%-12.26M25.88%-8.95M
Operating gains losses 787.10%5.44M96.19%-272K-131.91%-2.07M14,181.58%5.43M1,523.64%2.35M-137.63%-791K-338.47%-7.15M363.00%6.48M-95.80%38K-124.81%-165K
Depreciation and amortization 5.61%1.15M116.06%592K-103.90%-11K15.95%298K-1.82%270K2.54%1.09M-2.49%274K0.00%282K-5.17%257K21.15%275K
Other non cash items -102.32%-72K-97.56%52K-188.30%-317K-94.17%18K-42.81%175K68.53%3.1M544.55%2.13M-46.58%359K-65.97%309K537.14%306K
Change In working capital -768.02%-3.2M-362.08%-2.25M128.96%400K-150.75%-843K65.87%-514K76.84%-369K140.75%857K-115.06%-1.38M118.40%1.66M-505.93%-1.51M
-Change in receivables 184.66%1.4M17.88%-473K834.96%1.66M-101.08%-744K299.58%952K-461.62%-1.65M-183.72%-576K-113.36%-226K74.04%-370K4.41%-477K
-Change in prepaid assets -102.82%-84K-83.97%235K-118.85%-164K108.73%113K-113.82%-268K493.63%2.98M176.55%1.47M-89.79%870K86.22%-1.3M-41.10%1.94M
-Change in payables and accrued expense -260.61%-3.77M-1,424.09%-1.81M51.05%-909K-100.60%-21K63.44%-1.03M46.98%-1.05M118.87%137K-105.88%-1.86M79.60%3.49M-23.01%-2.81M
-Change in other current liabilities -13.61%-743K-14.12%-194K-11.90%-188K-19.38%-191K-8.97%-170K-13.15%-654K-13.33%-170K-13.51%-168K-11.11%-160K-14.71%-156K
Cash from discontinued investing activities
Operating cash flow 5.67%-30.97M18.45%-7.68M2.79%-7.31M3.20%-7.65M-4.23%-8.33M-55.38%-32.83M-38.75%-9.42M-382.78%-7.52M-1.93%-7.9M13.59%-7.99M
Investing cash flow
Cash flow from continuing investing activities 97.14%-20K0300K054.29%-320K-66.83%-699K001K-67.06%-700K
Net PPE purchase and sale ---20K--0--0--0---20K--0--0--0--0--0
Net intangibles purchase and sale 57.08%-300K--0--0--057.14%-300K-66.83%-699K--0--0--1K-67.06%-700K
Net other investing changes --300K--0--------------------------------
Cash from discontinued investing activities
Investing cash flow 97.14%-20K--0--300K--054.29%-320K-66.83%-699K--0--0--1K-67.06%-700K
Financing cash flow
Cash flow from continuing financing activities -99.29%327K197.50%39K0-100.29%-134K422K478.79%46.15M-40K-107.51%-594K46.78M0
Net issuance payments of debt ----------------------0--0------------
Net common stock issuance -99.92%39K--39K--0--------305.00%47M--0--0--------
Proceeds from stock option exercised by employees --487K--0--0--0--487K--0--0--0--0--0
Net other financing activities 76.67%-199K--0--0---134K---65K-92.12%-853K---40K-16.24%-594K--------
Cash from discontinued financing activities
Financing cash flow -99.29%327K197.50%39K--0-100.29%-134K--422K478.79%46.15M---40K-107.51%-594K--46.78M--0
Net cash flow
Beginning cash position 21.56%69.8M-39.52%48.7M-35.81%56.13M28.41%62.48M21.56%69.8M-15.78%57.42M28.78%80.52M65.07%87.43M-18.64%48.66M-15.78%57.42M
Current changes in cash -343.09%-30.66M19.21%-7.64M13.61%-7.01M-120.02%-7.79M5.34%-8.23M192.89%12.61M-39.32%-9.46M-176.79%-8.11M605.76%38.88M10.10%-8.69M
Effect of exchange rate changes 895.71%1.85M95.00%-63K-134.72%-418K1,433.64%1.43M1,397.14%908K-108.27%-233K-174.91%-1.26M220.04%1.2M-112.65%-107K-105.41%-70K
End cash Position -41.27%40.99M-41.27%40.99M-39.52%48.7M-35.81%56.13M28.41%62.48M21.56%69.8M21.56%69.8M28.78%80.52M65.07%87.43M-18.64%48.66M
Free cash flow 6.69%-31.29M18.45%-7.68M2.79%-7.31M3.19%-7.65M0.48%-8.65M-55.60%-33.53M-38.75%-9.42M-382.78%-7.52M-1.92%-7.9M10.10%-8.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -